I direct the Neuroendocrine Tumor Clinic and serve as a member of the Experimental Therapeutics Program and Thyroid Cancer Unit at the OSUCCC – James. Additionally, I’m Professor of Internal Medicine in the Division of Medical Oncology for The Ohio State University. I’ve published in the Journal of Clinical Investigation, Journal of Clinical Oncology, Journal of Immunology, Lancet, Nature Medicine and New England Journal of Medicine. I’m proud to have been named as a Best Doctor in America and an awardee of Business First’s Forty Under 40.
I feel very fortunate to be at The James. We love our patients! All our team members are passionate about what they do, and it’s been extremely rewarding working together to help our patients enjoy a better quality of life with positive outcomes.
N.H.L. Municipal Medical College
Sheth K. M. School of Post Grad
7/1/1990 - 6/30/1992
Additional languages I speak
Specialties and conditions I treat
- Medical Oncology
- Adrenal Gland Cancers
- Thyroid Cancer
- Carcinoma, Neuroendocrine
Locations where I practice
More about my work
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Shah has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Eisai, Inc.